These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 6441533)

  • 1. Protective effect of FR35447 on experimental cerebral infarction.
    Kamitani T; Katsuta K; Sakai S; Sakata Y; Motoyama Y; Horiai H; Ono T; Kikuchi H; Kumada S
    Arch Int Pharmacodyn Ther; 1984 Dec; 272(2):264-76. PubMed ID: 6441533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypotensive effect of 2-(5-chloro-2-phenoxyanilino)-2-imidazoline (FR35447).
    Kamitani T; Katamoto M; Tsujioka K; Terai T; Ohtsuka M; Ono T; Kikuchi H; Kumada S
    Jpn J Pharmacol; 1985 Oct; 39(2):251-61. PubMed ID: 3003434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nicergoline on platelet aggregation, plasma viscosity and erythrocyte deformability in geriatric patients with cerebral infarction. Preliminary report.
    Nagakawa Y; Akedo Y; Kaku S; Orimo H
    Arzneimittelforschung; 1990 Aug; 40(8):862-4. PubMed ID: 2122905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive effects of the cerebral circulation improver 6,7-dimethoxy-1-(3,4-dimethoxybenzyl)-4-([4-(2-methoxyphenyl)- 1-piperazinyl]methyl)isoquinoline on stroke symptoms in stroke-prone spontaneously hypertensive rats.
    Kuwahara T; Okada T; Nakamura K; Himori N; Yoshizaki H; Matsuura A; Koyama K; Satoh T; Nakamura K
    Arzneimittelforschung; 1987 Jul; 37(7):778-82. PubMed ID: 3675671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of GABA and piracetam on the development of experimental cerebral infarction in rats and platelet aggregation in patients with cerebrovascular disorders].
    Amroian EA; Vartazarian ND; Parsamian LK; Balian LS
    Biull Eksp Biol Med; 1990 Aug; 110(8):124-7. PubMed ID: 2127234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of diltiazem on platelet activation caused by ionophore A23187 plus ADP or epinephrine in subthreshold concentrations.
    Mehta P; Mehta J; Ostrowski N; Brigmon L
    J Lab Clin Med; 1983 Sep; 102(3):332-9. PubMed ID: 6411841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone potentiation of ionophore and ADP induced platelet aggregation: relationship to arachidonic acid metabolism.
    Pilo R; Aharony D; Raz A
    Thromb Haemost; 1981 Aug; 46(2):538-42. PubMed ID: 6795741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of etamsylate on platelet functions and arachidonic acid metabolism.
    Okuma M; Takayama H; Sugiyama T; Sensaki S; Uchino H
    Thromb Haemost; 1982 Dec; 48(3):330-3. PubMed ID: 6819650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vitamin E administration on platelet function and serum lipid peroxides in DOCA-salt hypertensive rats.
    Umegaki K; Saegusa H; Kurokawa M; Ichikawa T
    Thromb Haemost; 1991 Apr; 65(4):411-4. PubMed ID: 2057924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
    Han P; Boatwright C; Ardlie NG
    Thromb Haemost; 1983 Aug; 50(2):513-7. PubMed ID: 6314581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of prostacyclin and nitric oxide on deformability of red blood cells in septic shock in rats.
    Korbut R; Gryglewski RJ
    J Physiol Pharmacol; 1996 Dec; 47(4):591-9. PubMed ID: 9116326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet antiaggregant activity of plafibride ex vivo in rat, dog and rabbit.
    Bruseghini L; Vilageliu J; Freixes J
    Arzneimittelforschung; 1981; 31(10a):1790-5. PubMed ID: 6797443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Administration of procyanidolic oligomers in rats. Observed effects on changes in the cerebral biochemistry, secondary to multiple infarction].
    Cahn J; Borzeix MG
    Sem Hop; 1983 Jul; 59(27-28):2035-8. PubMed ID: 6312570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the antiplatelet effect of the stable epoprostenol analogue beraprost sodium and its mechanism of action in rats.
    Umetsu T; Murata T; Nishio S
    Arzneimittelforschung; 1989 Jan; 39(1):68-73. PubMed ID: 2541730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human platelet functions by verapamil.
    Ikeda Y; Kikuchi M; Toyama K; Watanabe K; Ando Y
    Thromb Haemost; 1981 Apr; 45(2):158-61. PubMed ID: 6789494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo studies with the stabilized epoprostenol analogue taprostene. Effects on platelet functions and blood clotting.
    Michel G; Seipp U
    Arzneimittelforschung; 1990 Aug; 40(8):932-8. PubMed ID: 2242087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staurosporine-independent platelet aggregation induced by the calcium ionophore ionomycin is inhibited by prostacyclin and sodium nitroprusside and stimulated by adrenaline.
    Doni MG; Alexandre A; Padoin E; Francesconi MA; Deana R
    Arch Biochem Biophys; 1993 Mar; 301(2):431-8. PubMed ID: 7681663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trifenagrel: a chemically novel platelet aggregation inhibitor.
    Abrahams SL; Hazen RJ; Batson AG; Phillips AP
    J Pharmacol Exp Ther; 1989 May; 249(2):359-65. PubMed ID: 2542526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arachidonic acid metabolism and platelet function in diabetics (author's transl)].
    Amado Señaris JA; Garcia-Conde Bru J; Merino Sanchez J; Benet Monforte I
    Sangre (Barc); 1981; 26(3):351-9. PubMed ID: 6794160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.